Colon cancer in inflammatory bowel disease: recent trends, questions and answers. (Q39904958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Colon cancer in inflammatory bowel disease: recent trends, questions and answers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

17 January 2020

main subject

0 references

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Bernard Flourié

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

S Viennot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Deleporte

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D Moussata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J-M Reimund

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

Gastroenterologie Clinique et Biologique

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

33 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

S190-201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Cancer risk in patients with inflammatory bowel disease: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Increased risk of large-bowel cancer in Crohn's disease with colonic involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

[Precancerous lesions and IBD - pathological aspects].

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Intracellular unesterified arachidonic acid signals apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

A proinflammatory cytokine inhibits p53 tumor suppressor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Ulcerative colitis and colorectal cancer. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

High frequency of early colorectal cancer in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Colorectal cancer prevention in ulcerative colitis: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Folate, Methionine, and Alcohol Intake and Risk of Colorectal Adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Statins and the risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

[Precancerous lesions and IBD endoscopic features]

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Flat neoplastic lesions of the colon and rectum detected by high-resolution video endoscopy and chromoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Magnifying colonoscopy with narrow band imaging system for the diagnosis of dysplasia in ulcerative colitis: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Confocal endomicroscopy in ulcerative colitis: differentiating dysplasia-associated lesional mass and adenoma-like mass

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

[Recommendations for clinical practice for the treatment of ulcerative colitis]

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

[Treatment of ulcerative colitis: special situations]

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Colorectal cancer: screening

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Most dysplasia in ulcerative colitis is visible at colonoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Detection of APC mutations in fecal DNA from patients with colorectal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Ulcerative colitis with low-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Surveillance in the routine management of ulcerative colitis: The predictive value of low-grade dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2809%2973154-9

7 January 2021

10.1016/S0399-8320(09)73154-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20117342%20AND%20SRC:MED&resulttype=core&format=json

release_tevi2tj42nc4ram76varw6ttnq

17 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tevi2tj42nc4ram76varw6ttnq

24 November 2022

mapped directly with Wikidata item

1 reference